Publication | Closed Access
Continuous Infusion of Recombinant Factor VIIa (NovoSeven®) in the Treatment of a Patient with Type III von Willebrand’s Disease and Alloantibodies against von Willebrand Factor
39
Citations
0
References
2000
Year
ThrombosisAutoimmune DiseaseVon Willebrand FactorImmunologyHematologyRecombinant Factor ViiaHemostasisAutoimmunityPharmacotherapyCoagulopathyBleeding DisorderMedicineAnticoagulantContinuous Infusion
Continuous Infusion of Recombinant Factor VIIa (NovoSeven®) in the Treatment of a Patient with Type III von Willebrand’s Disease and Alloantibodies against von Willebrand Factor -